Faruqi and Faruqui, LLP Logo
Share this page

Omnicell, Inc. (OMCL)

(NasdaqGS: OMCL)


INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Omnicell, Inc. (OMCL) To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Omnicell, Inc. (“Omnicell” or the “Company”) (NasdaqGS: OMCL).

The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that (1) a “side letter” arrangement existed between Omnicell and a key customer for certain discounts and Company products that were provided at no cost, but which were not reflected in final invoices paid by the customer; and (2) the Company lacked adequate internal controls over its financial reporting.

After market close on March 2, 2015, Omnicell disclosed that it would be unable to file its Annual Report Form 10-K the year ended December 31, 2014 as “additional time is required by the Company to investigate a notice received on February 27, 2015 from a Company employee alleging, among other things, the existence of a ‘side letter’ agreement with a Company customer for certain discounts and Company products that were to be provided at no cost, but which were not reflected in the final invoices paid by the customer.”

On this unexpected news, Omnicell shares dropped by over 6% to close at $33.08 per share on March 3, 2015.

Take Action

If you invested in Omnicell stock or options between May 2, 2014 and March 2, 2015 and would like to discuss your legal rights, please contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Omnicell’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 03/20/2015

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.